289 related articles for article (PubMed ID: 16228060)
1. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
[TBL] [Abstract][Full Text] [Related]
2. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
3. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
4. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
6. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
7. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E;
Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
Heijnen EM; Eijkemans MJ; Hughes EG; Laven JS; Macklon NS; Fauser BC
Hum Reprod Update; 2006; 12(1):13-21. PubMed ID: 16123051
[TBL] [Abstract][Full Text] [Related]
9. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
12. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
13. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
15. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
16. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
17. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
19. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
[TBL] [Abstract][Full Text] [Related]
20. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
